F Kerangueven

736 citations
15 papers · 609 indexed · h-index 10
Topics
RNA modifications and cancer (5 papers)BRCA gene mutations in cancer (5 papers)RNA Research and Splicing (4 papers)

In The Last Decade

F Kerangueven

15 papers receiving 576 citations

Peers

F Kerangueven
Comparison fields: 5 of 49
  • Molecular Biology 326
  • Genetics 325
  • Cancer Research 214
  • Pathology and Forensic Medicine 212
  • Oncology 164
Replace Keri Fair with:
Keri Fair United States
Kenneth Offit United States
Florence Allione France
Markéta Janatová Czechia
Anitta Tamminen Finland
Munaza Ahmed United Kingdom
Fitsum Hagos United States
Elizabeth L. Schubert United States
Agnès Chompret France
Jūlı́us Guðmundsson Iceland
F Kerangueven relative to Keri Fair United States Keri Fair's profile →
Citations per field
00.5×
Keri Fair · 1×
Citations per year

Countries citing papers authored by F Kerangueven

Since Specialization
Citations

This map shows the geographic impact of F Kerangueven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Kerangueven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Kerangueven more than expected).

Fields of papers citing papers by F Kerangueven

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F Kerangueven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Kerangueven. The network helps show where F Kerangueven may publish in the future.

Co-authorship network of co-authors of F Kerangueven

This figure shows the co-authorship network connecting the top 25 collaborators of F Kerangueven. A scholar is included among the top collaborators of F Kerangueven based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F Kerangueven. F Kerangueven is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 12
2 54
3
Genome-wide search for loss of heterozygosity shows extensive genetic diversity of human breast carcinomas.
137
4 31
5
Germ line mutation at BRCA1 affects the histoprognostic grade in hereditary breast cancer.
129
6 4
7 1
8
Truncation at conserved terminal regions of BRCA1 protein is associated with highly proliferating hereditary breast cancers.
49
9 2
10 38
11
Loss of heterozygosity and linkage analysis in breast carcinoma: indication for a putative third susceptibility gene on the short arm of chromosome 8.
105
12 4
13 8
14
Effects of transforming growth factor beta, tumor necrosis factor alpha, interferon gamma and LIF-HILDA on the proliferation of acute myeloid leukemia cells.
9
15
Coexpression of the genes for interleukin 6 and its receptor without apparent involvement in the proliferation of acute myeloid leukemia cells.
26

About F Kerangueven

F Kerangueven is a scholar working on Genetics, Pathology and Forensic Medicine and Cancer Research, having authored 15 papers that have together received 609 indexed citations. Recurring topics across this work include RNA modifications and cancer (5 papers), BRCA gene mutations in cancer (5 papers) and RNA Research and Splicing (4 papers). The work is most often cited by research in Cancer Research (214 citations), Pathology and Forensic Medicine (212 citations) and Genetics (325 citations). F Kerangueven has collaborated with scholars based in France, Netherlands and United States. Frequent co-authors include Daniel Birnbaum, François Eisinger, Michel Longy, Hagay Sobol, Florence Allione, T Noguchi, Anne Vincent‐Salomon, Clément Bailly, J Jacquemier and Laurent Essioux. Their work appears in journals such as Oncogene, European Journal of Cancer and Genomics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026